Our take
TiRobot is China's leading orthopedic surgical robot and one of few that covers spine, trauma, and joint replacement on one machine. TINAVI reports more than 180,000 cases at more than 200 hospitals across 31 provinces by mid 2026.2,4
Outside China it is an early option. Its CE MDR certificate covers spinal navigation and positioning, it publishes no prices, and it lost 183 million yuan in 2025 on 279 million yuan of revenue.4,6
Scores by criterion
Pricing transparency, 3.0: TINAVI publishes no prices for TiRobot or its instruments.3
Product maturity, 7.5: TINAVI was founded in 2005, received China's first orthopedic robot registration in 2010, launched TiRobot II in 2021, and holds more than 300 patents.1,2
Deployment evidence, 7.5: TINAVI reports more than 180,000 TiRobot cases at more than 200 medical institutions in 31 provinces by the end of the second quarter of 2026. Nearly all of that use is in China.2
Company durability, 5.5: TINAVI has been listed on the Shanghai STAR Market since 2020. Its 2025 revenue rose 55.9% to 279 million yuan, but its net loss widened to 183 million yuan from 121 million yuan.5,6
Ease of integration, 6.0: TiRobot II adds integrated arm control, one-button screw selection, a C-arm tracker, and real-time planning to simplify the workflow. English product documentation is thin, and its EU clearance covers spine use.3,4
Each criterion is defined on our methodology page.
Who uses TINAVI and what it's for
The buyer is a hospital in China, or a European spine center, that wants one robot for spine, pelvis, femoral neck, and joint procedures rather than separate systems.2,4
Buyers should compare it with Stryker's Mako, Globus Medical's ExcelsiusGPS, THINK Surgical's TMINI, and eCential Robotics' spine platform.3
TiRobot and TiRobot II
TiRobot covers spine surgery at all levels from cervical to sacral, trauma surgery in the pelvis, acetabulum, and limbs, and joint replacement. TINAVI says it is the only robot that handles all three fields on one device.2,4
TiRobot II, the latest system, adds a multi-function arm, a sterile surgical display, and a simplified workflow, and TINAVI also sells a 5G remote surgery system and robot instruments.3,1
Clinical use
TINAVI's case count grew from more than 50,000 in 2023 and 90,000 in 2024 to more than 150,000 by the end of 2025 and more than 180,000 by mid 2026.1,2
TINAVI signed a commercial and research agreement with Johnson & Johnson Medical in 2019 and a strategic agreement with Shandong Weigao in 2022.1,5
Pricing
TINAVI does not publish prices. Buyers should ask for the system price, per-case instrument costs, and service terms, and confirm which indications are cleared in their country.3,4
Company and revenue
TINAVI was founded in 2005 and is headquartered in Beijing, China. Chairman Zhang Songgen was its largest listed shareholder at the end of 2025 with 16.7%.1,6
Our dollar figure converts 279 million yuan at about 7.2 yuan per dollar.6
Competitive landscape
| Company | Product | Pricing model | Deployment evidence | Where TINAVI wins or loses |
|---|---|---|---|---|
| TINAVI | TiRobot II for spine, trauma, and joint surgery3 | Quote; no prices published3 | More than 180,000 cases at more than 200 hospitals2 | Broad indications; mostly China; loss-making |
| Stryker Mako SmartRobotics | Mako 4 with CT planning and AccuStop haptics8 | Quote; no prices published8 | More than two million procedures in more than 45 countries7 | Mako wins on the largest base of robotic joint procedures. TINAVI wins on one robot for spine, trauma, and joint cases. |
| Globus Medical ExcelsiusGPS | Rigid arm plus full navigation, CT or fluoroscopy11 | Quote; spec sheet by request11 | 141.0 million dollars of enabling technology sales in 202510 | ExcelsiusGPS wins on rigid trajectory guidance with flexible imaging. TINAVI wins on one robot for spine, trauma, and joint cases. |
| THINK Surgical TMINI | Handheld, wireless knee robot with TPLAN planning12 | Quote; demo by request12 | 5,000 procedures by May 202612 | TMINI wins on a small knee robot open to many implants. TINAVI wins on one robot for spine, trauma, and joint cases. |
| eCential Robotics | Imaging, navigation, and robotics in one platform13 | Quote; demo by request13 | More than 3,500 surgeries13 | eCential wins on built-in 3D imaging with any brand of screw. TINAVI wins on one robot for spine, trauma, and joint cases. |
| Curexo | CUVIS-joint fully automatic knee robot, CUVIS-spine navigation, MorningWalk14 | Quote14 | More than 100 CUVIS-joint installs; Korea, India, US, Australia launches15 | Curexo wins on fully automatic bone cutting on an open implant platform. TINAVI wins on trauma and spine coverage at a lower price in China. |
Limits
No published price.3
Loss-making: a 183 million yuan net loss in 2025.6
EU certification covers spine navigation and positioning only.4
What customers say
Where it helps
One TiRobot covers spine, trauma, and joint replacement procedures.2
Where it falls short
English product information on TINAVI's site is limited.3
Leadership
TINAVI does not publish a leadership team page in English. Its chairman, Zhang Songgen, was elected vice chairman of the medical robot branch of the Chinese Society of Biomedical Engineering and was TINAVI's largest listed shareholder at the end of 2025.1,6
Sources
- TINAVI, English homepage with company history, accessed November 9, 2026
- TINAVI, About TINAVI, accessed November 9, 2026
- TINAVI, TiRobot II product page, accessed November 9, 2026
- TINAVI, TiRobot orthopedic surgical robot obtained CE MDR certification, August 19, 2024, accessed November 9, 2026
- TINAVI, TINAVI Was Reported by the Special Issue of Nature, June 30, 2020, accessed November 9, 2026
- Eastmoney (China Securities Journal), TINAVI 2025 total operating revenue 279 million yuan, up 55.9%, April 29, 2026, accessed November 9, 2026
- Stryker, 2025 Comprehensive Report, accessed November 9, 2026
- Stryker, Mako SmartRobotics overview, accessed November 9, 2026
- Stryker, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
- Globus Medical, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
- Globus Medical, ExcelsiusGPS product page, accessed November 9, 2026
- THINK Surgical, homepage and news, accessed November 9, 2026
- eCential Robotics, homepage, accessed November 9, 2026
- Curexo, CUVIS-joint, accessed November 13, 2026
- Curexo, History, accessed November 13, 2026
- Curexo, 2025 business report filed with the Korea Exchange (March 17, 2026), accessed November 13, 2026

